Shareholder Votes

Grand Canyon Education, Inc. shareholders approved Approval of the adoption of the 2026 Equity Incentive Plan at the 2026-06-10 meeting.

“The stockholders approved the adoption of the 2026 Equity Incentive Plan.”

Grand Canyon Education, Inc. shareholders approved Election of Directors at the 2026-06-10 meeting.

“The stockholders elected the nominees listed below as directors of the Company, each to serve until the Company’s 2027 annual meeting of stockholders or until his or her respective successor is elected and qualified or until his or her earlier resignation or removal.”

Voyager Therapeutics, Inc. shareholders approved Amendment to Fifth Amended and Restated Certificate of Incorporation to increase authorized shares of capital stock from 125,000,000 to 245,000,000 and authorized shares of common stock from 120,000,000 to 240,000,000.

“Voyager’s stockholders approved an amendment to the Fifth Amended and Restated Certificate of Incorporation of Voyager Therapeutics, Inc. to increase the number of authorized shares of the Company’s capital stock from 125,000,000 shares to 245,000,000 shares and increase the number of authorized shares of common stock from 120,000,000 shares of common stock to 240,000,000 shares of common stock. The results of the stockholders’ vote with respect to such proposal were as follows: For Against Abstain Broker Non-Votes 43,464,491 2,593,426 108,424 -”

Voyager Therapeutics, Inc. shareholders approved Ratification of appointment of Ernst & Young LLP as independent registered public accounting firm for fiscal year ending December 31, 2026 at the 2026-12-31 meeting.

“Voyager’s stockholders ratified the appointment of Ernst & Young LLP as Voyager’s independent registered public accounting firm for the fiscal year ending December 31, 2026. The results of the stockholders’ vote with respect to such ratification were as follows: For Against Abstain Broker Non-Votes 45,902,883 108,561 154,897 -”

Voyager Therapeutics, Inc. shareholders approved Non-binding advisory proposal regarding compensation of named executive officers.

“Voyager’s stockholders approved a non-binding, advisory proposal regarding the compensation of Voyager’s named executive officers. The results of the stockholders’ vote with respect to such proposal were as follows: For Against Abstain Broker Non-Votes 32,041,373 910,087 157,037 13,057,844”

Voyager Therapeutics, Inc. shareholders approved Election of Class II directors.

“Voyager’s stockholders elected James A. Geraghty, Steven Hyman, M.D., and Alfred Sandrock, M.D., Ph.D., each to serve as a Class II director until the 2029 Annual Meeting of Stockholders and until such nominee’s successor has been duly elected and qualified, subject to such nominee’s earlier death, resignation, or removal. The results of the stockholders’ vote with respect to the election of such Class II directors were as follows: Name Votes For Votes Withheld Broker Non-Votes James A. Geraghty 23,336,364 9,772,133 13,057,844 Steven Hyman, M.D. 30,442,488 2,666,009 13,057,844 Alfred Sandrock, M.D., Ph.D. 31,890,428 1,218,069 13,057,844”

Figure Technology Solutions, Inc. shareholders approved Ratification of KPMG LLP as independent registered public accounting firm for fiscal year ending December 31, 2026.

“The proposal received the following votes: Votes For Votes Against Abstentions Broker Non-Votes 454,618,693 109,576 577,493 0”

Figure Technology Solutions, Inc. shareholders approved Election of eight directors to serve until 2027 annual meeting.

“The votes regarding the election of the directors were as follows: Name Votes For Withheld Broker Non-Votes Michael Tannenbaum 413,995,718 3,944,397 37,365,647 Adam Boyden 399,244,046 18,696,069 37,365,647 Michael Cagney 403,744,858 14,195,257 37,365,647 David Katsujin Chao 387,760,177 30,179,838 37,365,647 Lesley Goldwasser 401,970,390 15,969,725 37,365,647 Sachin Jaitly 414,256,352 3,683,763 37,365,647 Daniel Morehead 403,685,452 14,254,663 37,365,647 June Ou 387,336,666 30,603,449 37,365,647”

SIGA TECHNOLOGIES INC shareholders approved Approval of an amendment to the 2010 Plan to increase the maximum number of shares of Common Stock authorized for issuance under the 2010 Plan from 8,500,000 shares to 15,000,000 shares at the 2026-06-09 meeting.

“(4) Approval of an amendment to the 2010 Plan to increase the maximum number of shares of Common Stock authorized for issuance under the 2010 Plan from 8,500,000 shares to 15,000,000 shares. For Against Abstain 38,823,234 12,390,841 20,559 With respect Proposals (1), (2) and (4) there were 11,201,471 broker "non votes."”

SIGA TECHNOLOGIES INC shareholders approved Approval of the non-binding advisory resolution on the compensation of the Company's named executive officers at the 2026-06-09 meeting.

“(3) Approval of the non-binding advisory resolution on the compensation of the Company's named executive officers. For Against Abstain 48,744,042 2,404,456 86,136”

SIGA TECHNOLOGIES INC shareholders approved Ratification of the appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm of the Company for the fiscal year ending December 31, 2026 at the 2026-06-09 meeting.

“(2) Ratification of the appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm of the Company for the fiscal year ending December 31, 2026. For Against Abstain 62,040,317 343,043 52,745”

SIGA TECHNOLOGIES INC shareholders approved Election of eight director nominees at the 2026-06-09 meeting.

“(1) Election of the following individuals to hold office as directors of the Company for terms of one year. Name For Withheld Jaymie A. Durnan 45,259,891 5,974,743 Harold E. Ford, Jr 50,828,584 406,050 General John M. Keane 50,710,136 524,498 Joseph W. Marshall, III 45,722,184 5,512,450 Gary J. Nabel, M.D., Ph.D. 46,871,987 4,362,647 Julian Nemirovsky 49,445,175 1,789,459 Diem Nguyen, Ph.D., MBA 49,884,604 1,350,030 Holly L. Phillips, M.D. 48,612,659 2,621,975”

Bicara Therapeutics Inc. shareholders approved Ratification of KPMG LLP as independent registered public accounting firm for fiscal year 2026 at the 2026-06-09 meeting.

“Proposal 2: Ratification of KPMG LLP The Company's stockholders ratified the appointment of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026, with the votes cast as follows: Votes For Votes Against Votes Abstaining Ratification of appointment of KPMG LLP 55,914,602 8,815 1,570”

Bicara Therapeutics Inc. shareholders approved Election of Class II Directors at the 2026-06-09 meeting.

“Proposal 1: Election of Directors The Company's stockholders elected each of the following individuals to serve as class II directors for a three-year term ending at the Company's 2029 annual meeting of stockholders and until his or her successor has been duly elected and qualified, or until his or her earlier death, resignation or removal, with the votes cast as follows: Director Votes For Votes Withheld Broker Non-Votes Christopher Bowden, M.D. 48,558,710 5,145,418 2,220,859 Carolyn Ng, Ph.D. 47,431,269 6,272,859 2,220,859”

EXPONENT INC shareholders approved Advisory Vote on Executive Compensation for Fiscal 2025 at the 2026-06-04 meeting.

“Our stockholders approved, on an advisory basis, the fiscal 2025 compensation of our named executive officers in accordance with SEC rules.”

EXPONENT INC shareholders approved Ratification of KPMG as our Independent Registered Public Accountants for Fiscal 2026 at the 2026-06-04 meeting.

“Our stockholders ratified our selection of KPMG LLP as our independent registered public accounting firm to audit our financial statements for the fiscal year ending January 1, 2027.”

EXPONENT INC shareholders approved Election of Directors at the 2026-06-04 meeting.

“Our stockholders elected George H. Brown, Catherine Ford Corrigan, Ph.D., Carol Lindstrom, Karen A. Richardson, Richard L. Schlenker Jr. and Debra L. Zumwalt.”

Solid Biosciences Inc. shareholders approved Non-binding advisory vote on compensation paid to named executive officers at the 2026-06-10 meeting.

“The Company’s stockholders approved the non-binding, advisory vote on the compensation paid to its named executive officers.”

Solid Biosciences Inc. shareholders approved Amendment to Certificate of Incorporation to increase authorized common stock from 240,000,000 to 480,000,000 at the 2026-06-10 meeting.

“The Company’s stockholders approved an amendment to the Company’s Certificate of Incorporation, as amended, to increase the number of authorized shares of the Company’s common stock from 240,000,000 to 480,000,000 (the “Share Increase Amendment”).”

Solid Biosciences Inc. shareholders approved Ratification of PricewaterhouseCoopers LLP as independent registered public accounting firm at the 2026-06-10 meeting.

“The Company’s stockholders ratified the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026.”

Solid Biosciences Inc. shareholders approved Ratification of Ilan Ganot as a Class I director (advisory) at the 2026-06-10 meeting.

“The Company’s stockholders ratified the appointment of Ilan Ganot, on an advisory basis, as a Class I director to serve until the 2028 Annual Meeting of Stockholders.”

Solid Biosciences Inc. shareholders approved Election of Clare Kahn, Adam Stone and Lynne Sullivan as Class II directors at the 2026-06-10 meeting.

“The Company’s stockholders elected Clare Kahn, Adam Stone and Lynne Sullivan as Class II directors to serve until the 2029 Annual Meeting of Stockholders, each director to hold office until his or her successor has been duly appointed and qualified.”

Upstream Bio, Inc. shareholders approved Ratification of Appointment of Independent Registered Public Accounting Firm at the 2026-06-09 meeting.

“Proposal 2 - Ratification of Appointment of the Company’s Independent Registered Public Accounting Firm The Company’s stockholders ratified the appointment of PwC as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026. The results of Proposal 2 were as follows: For Against Abstain 47,951,313 143,251 6,203”

Upstream Bio, Inc. shareholders approved Election of Class II Directors at the 2026-06-09 meeting.

“The Company’s stockholders approved the Class II director nominees recommended for election in Proposal 1 at the Annual Meeting. The results of Proposal 1 were as follows: Class II Director Nominee For Withheld Broker Non-Votes H. Edward Fleming, Jr., M.D. 40,715,035 3,367,258 4,018,474 Liam Ratcliffe, M.B.Ch.B., Ph.D., M.B.A. 43,812,021 270,272 4,018,474”

SenesTech, Inc. shareholders approved Ratification of M&K CPAS, PLLC as independent registered public accounting firm for fiscal year ending December 31, 2026 at the 2026-06-09 meeting.

“Our stockholders ratified the appointment of M&K CPAS, PLLC as our independent registered public accounting firm for the fiscal year ending December 31, 2026. Votes For Votes Against Abstentions Broker Non-Votes Ratification of M&K CPAS, PLLC as our independent registered public accounting firm 2,754,180 225,124 71,038 —”

SenesTech, Inc. shareholders approved Amendment to 2018 Equity Incentive Plan to increase shares by 1,200,000 at the 2026-06-09 meeting.

“Our stockholders approved an amendment to our 2018 Equity Incentive Plan (the “2018 Plan”) to increase the number of shares of common stock available for issuance under the 2018 Plan by 1,200,000 shares (the “2018 Amended Plan”). Votes For Votes Against Abstentions Broker Non-Votes 2018 Amended Plan 1,155,241 204,833 4,760 1,685,508”

SenesTech, Inc. shareholders approved Non-binding advisory vote on compensation of named executive officers for fiscal 2025 at the 2026-06-09 meeting.

“Our stockholders approved, on a non-binding advisory basis, the compensation of our named executive officers for fiscal 2025 (“Say-on-Pay”). Votes For Votes Against Abstentions Broker Non-Votes Say-on-Pay Proposal 1,184,641 122,408 57,785 1,685,508”

SenesTech, Inc. shareholders approved Election of Class I Directors at the 2026-06-09 meeting.

“Our stockholders elected the individuals listed below as a Class I directors at the Annual Meeting, each to serve for a three-year term until the 2029 annual meeting of stockholders and until their successors are duly elected and qualified . Director Votes For Votes Withheld Broker Non-Votes Jake S. Leach 1,293,056 71,778 1,685,508 Joshua M. Moss 1,319,573 45,261 1,685,508”

Weave Communications, Inc. shareholders approved Ratify appointment of PricewaterhouseCoopers LLP as independent registered public accounting firm for fiscal year ending December 31, 2026 at the 2026-06-10 meeting.

“To ratify the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026: For Against Abstain Broker Non-Votes 63,358,833 12,382 16,200 —”

Weave Communications, Inc. shareholders approved Election of two Class I directors at the 2026-06-10 meeting.

“Nominee For Withheld Broker Non-Votes George Scanlon 26,515,218 15,132,019 21,740,178 Debra Tomlin 26,375,601 15,271,636 21,740,178”

Addus HomeCare Corp shareholders approved Advisory, non-binding approval of the Company’s compensation of its named executive officers as set forth in the Proxy Statement at the 2026-06-10 meeting.

“The approval, on an advisory, non-binding basis, of the Company’s compensation of its named executive officers as set forth in the Proxy Statement: For Against Abstain Broker Non-Votes 15,632,614 1,304,367 31,320 589,033”

Addus HomeCare Corp shareholders approved Ratification of the appointment of PricewaterhouseCoopers LLP as the Company’s independent auditor for fiscal year 2026 at the 2026-06-10 meeting.

“The ratification of the appointment of PricewaterhouseCoopers LLP, an independent registered public accounting firm, as the Company’s independent auditor for the fiscal year ending December 31, 2026: For Against Abstain Broker Non-Votes 17,538,710 10,612 8,012 —”

Addus HomeCare Corp shareholders approved Election of Michael Earley and Veronica Hill-Milbourne, to serve as Class II directors for terms expiring at the 2029 annual meeting at the 2026-06-10 meeting.

“The election of Michael Earley and Veronica Hill-Milbourne, to serve as Class II directors for terms expiring at the 2029 annual meeting of the Company’s stockholders: Name For Withhold Authority Broker Non-Votes (a) Michael Earley 15,527,672 1,440,629 589,033 (b) Veronica Hill-Milbourne 16,436,095 532,206 589,033”

Sable Offshore Corp. shareholders approved Ratification of the appointment of Ham, Langston & Brezina, L.L.P., as the Company’s independent registered public accounting firm at the 2026-06-10 meeting.

“Ratification of the appointment of Ham, Langston & Brezina, L.L.P., as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026: Votes For Votes Against Abstentions 115,162,359 28,522 243,667”

Sable Offshore Corp. shareholders approved Election of one Class II director at the 2026-06-10 meeting.

“Election of one Class II director to serve until the Company’s 2029 Annual Meeting of Stockholders, and until his successor is duly elected and qualified: Votes For Votes Against Abstentions Broker Non-votes Gregory P. Pipkin 78,146,530 1,507,507 15,327,544 20,452,967”

Aquestive Therapeutics, Inc. shareholders approved Ratification of appointment of KPMG LLP as independent registered public accounting firm at the 2026-06-10 meeting.

“The appointment of KPMG LLP as the independent registered public accounting firm for the Company for the fiscal year ending December 31, 2026 was ratified. Votes For Votes Against Votes Abstaining 78,804,323 910,690 346,313”

Aquestive Therapeutics, Inc. shareholders approved Advisory vote to approve executive compensation at the 2026-06-10 meeting.

“The proposal to approve, on a non-binding advisory basis, executive compensation was approved for the one year. Votes For Votes Against Votes Abstaining Broker Non-Votes 37,798,609 3,192,381 1,604,754 37,465,582”

Aquestive Therapeutics, Inc. shareholders approved Election of Class II directors at the 2026-06-10 meeting.

“The following director nominees were elected to serve as Class II members of the Board of Directors, to serve for a three-year term until the Company's 2029 Annual Meeting of Stockholders and until his or her successor is duly elected and qualified: Nominee Votes For Votes Against Votes Abstaining Broker Non-Votes Gregory B. Brown, M.D. 41,373,033 — 1,222,711 37,465,582 John S. Cochran 36,914,899 — 5,680,845 Abigail L. Jenkins 39,094,166 — 3,501,578”

Purple Innovation, Inc. shareholders approved Ratification of the selection of BDO USA, LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026 at the 2026-06-09 meeting.

“Ratification of the selection of BDO USA, LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026”

Purple Innovation, Inc. shareholders approved Approval, on an advisory basis, of the compensation of the Company’s named executive officers as set forth in the Proxy Statement at the 2026-06-09 meeting.

“Approval, on an advisory basis, of the compensation of the Company’s named executive officers as set forth in the Proxy Statement”

Purple Innovation, Inc. shareholders approved Election of eight directors to serve until their successors are duly elected and qualified at the next annual meeting of stockholders or until their earlier death, resignation or removal at the 2026-06-09 meeting.

“Election of eight directors to serve until their successors are duly elected and qualified at the next annual meeting of stockholders or until their earlier death, resignation or removal”

Lulu's Fashion Lounge Holdings, Inc. shareholders approved Approval of an amendment to the Company's Certificate of Incorporation to provide exculpation to certain officers of the Company as permitted by amendments to the Delaware General Corporation Law. at the 2026-06-09 meeting.

“Proposal 4 — Approval of an amendment to the Company’s Certificate of Incorporation to provide exculpation to certain officers of the Company as permitted by amendments to the Delaware General Corporation Law. ​ ​ ​ ​ FOR ​ AGAINST ​ ABSTAIN ​ BROKER NON-VOTE ​ ​ ​ ​ ​ ​ ​ 2,328,832 ​ 7,790 ​ 108 ​ 383,835”

Lulu's Fashion Lounge Holdings, Inc. shareholders approved Approval of an amendment to the Company's Fourth Amended and Restated Certificate of Incorporation to decrease the number of authorized shares of the Company's common stock from 250,000,000 to 15,000,000 and decrease the number of authorized shares of the Company's preferred stock from 10,000,000 to at the 2026-06-09 meeting.

“Proposal 3 — Approval of an amendment to the Company’s Fourth Amended and Restated Certificate of Incorporation (the “Certificate of Incorporation”) to decrease the number of authorized shares of the Company’s common stock from 250,000,000 to 15,000,000 and decrease the number of authorized shares of the Company’s preferred stock from 10,000,000 to 500,000. ​ ​ ​ ​ ​ ​ FOR ​ AGAINST ​ ABSTAIN ​ BROKER NON-VOTE ​ ​ ​ ​ ​ ​ ​ 2,333,879 ​ 2,839 ​ 12 ​ 383,835”

Lulu's Fashion Lounge Holdings, Inc. shareholders approved Ratification of the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending January 3, 2027. at the 2026-06-09 meeting.

“Proposal 2 — Ratification of the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending January 3, 2027. ​ FOR ​ AGAINST ​ ABSTAIN ​ BROKER NON-VOTE ​ ​ ​ ​ ​ ​ ​ 2,700,276 ​ 20,130 ​ 159 ​ 0”

Lulu's Fashion Lounge Holdings, Inc. shareholders approved Election of two Class II directors to serve for a term of office expiring on the date of the 2029 annual meeting of stockholders, and until their respective successors have been duly elected and qualified or until each such director's earlier death, resignation or removal. at the 2026-06-09 meeting.

“Proposal 1 — Election of two Class II directors to serve for a term of office expiring on the date of the 2029 annual meeting of stockholders, and until their respective successors have been duly elected and qualified or until each such director’s earlier death, resignation or removal. ​ ​ ​ ​ ​ FOR ​ WITHHOLD ​ BROKER NON-VOTE Anisa Kumar 2,301,513 ​ 35,217 ​ 383,835 Crystal Landsem 2,324,327 ​ 12,403 ​ 383,835”

GRAYBAR ELECTRIC CO INC shareholders approved Election of Directors at the 2026-06-10 meeting.

“the Company’s Board of Directors (as previously reported to the U. S. Securities and Exchange Commission) was re-elected in its entirety.”

ASCENT INDUSTRIES CO. shareholders approved Ratification of the appointment of Baker Tilly US, LLP as Ascent Industries Co.'s independent registered public accounting firm for the fiscal year ending December 31, 2026 at the 2026-06-10 meeting.

“Proposal 3: Ratification of the appointment of Baker Tilly US, LLP as Ascent Industries Co.'s independent registered public accounting firm for the fiscal year ending December 31, 2026 Votes For Votes Against Abstain 7,417,001 18,131 15,971”

ASCENT INDUSTRIES CO. shareholders approved Advisory approval of Ascent Industries Co.'s named executive officer compensation for fiscal 2025 at the 2026-06-10 meeting.

“Proposal 2: Advisory approval of Ascent Industries Co.'s named executive officer compensation for fiscal 2025 Votes For Votes Against Abstain Broker Non-Votes 5,763,830 52,369 17,682 1,617,222”

ASCENT INDUSTRIES CO. shareholders approved Election of Directors at the 2026-06-10 meeting.

“Proposal 1: Election of Directors Name Votes For Votes Against Abstain Broker Non-Votes Carmen J. Giannantonio 5,752,309 63,111 18,461 1,617,222 Henry L. Guy 3,762,153 2,053,805 17,923 1,617,222 Christopher G. Hutter 5,296,943 516,757 20,181 1,617,222 J. Bryan Kitchen 5,756,742 59,922 17,217 1,617,222 Aldo J. Mazzaferro 3,777,522 2,049,057 7,302 1,617,222 Jeremy F. Rohen 5,615,350 200,037 18,494 1,617,222 Benjamin Rosenzweig 5,063,441 752,215 18,225 1,617,222”

Crocs, Inc. shareholders approved Approve the Crocs, Inc. 2026 Equity Incentive Plan at the 2026-06-09 meeting.

“The proposal to approve the Crocs, Inc. 2026 Equity Incentive Plan was approved based on the following votes”